
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.72 | 25.60 | 24.88 |
Shares | 99.28 | 99.28 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 27.42 | 16.43 |
Price to Book | 5.22 | 2.50 |
Price to Sales | 4.32 | 1.92 |
Price to Cash Flow | 17.42 | 11.06 |
Dividend Yield | 1.36 | 3.15 |
5 Years Earnings Growth | 10.38 | 9.32 |
Name | Net % | Category Average |
---|---|---|
Industrials | 26.93 | 22.69 |
Technology | 22.18 | 12.76 |
Consumer Cyclical | 20.38 | 9.25 |
Healthcare | 19.30 | 13.53 |
Basic Materials | 6.36 | 7.14 |
Consumer Defensive | 4.85 | 8.07 |
Number of long holdings: 45
Number of short holdings: 12
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 8.35 | 490.4 | +2.87% | |
Ryanair | IE00BYTBXV33 | 7.03 | 27.5000 | 0.00% | |
Moncler SpA | IT0004965148 | 5.97 | 54.00 | +1.28% | |
SAP | DE0007164600 | 5.41 | 272.350 | +0.52% | |
ASML Holding | NL0010273215 | 5.41 | 667.60 | +1.31% | |
Ferrari NV | NL0011585146 | 5.40 | 482.61 | +0.47% | |
EssilorLuxottica | FR0000121667 | 4.78 | 248.30 | +1.14% | |
L'Oreal | FR0000120321 | 4.73 | 381.35 | -0.24% | |
Adyen | NL0012969182 | 4.65 | 1,724.80 | +1.15% | |
Rational AG | DE0007010803 | 4.60 | 743.25 | +0.27% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Accumulation Shares Class C | 1.9B | 4.16 | 10.59 | 8.03 | ||
Income Shares Class D | 1.9B | 4.18 | 10.61 | 8.04 | ||
Man GLG UK Income Fund Retail Accum | 1.9B | 4.02 | 9.80 | 7.29 | ||
Man GLG UK Income Fund Retail Incom | 1.9B | 4.02 | 9.81 | 7.26 | ||
GB00BFH3NC99 | 1.45B | 1.48 | 10.32 | 6.91 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review